BMS-684
Product Specifications
UNSPSC Description
BMS-684 is a selective DGKα inhibitor with an IC50 of 15 nM. BMS-684 inhibits DGKα kinase activity with >100-fold selectivity over the related DGK type I family members DGKβ and DGKγ. BMS-684 does not inhibit any of the other seven DGK isozymes[1].
Target Antigen
DGK
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-684.html
Solubility
DMSO : 14.29 mg/mL (ultrasonic;warming)
Smiles
CN(C1=CC=CC=C1C(N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=C5[N+]([O-])=O)C5=O
Molecular Weight
454.52
References & Citations
[1]Michael Wichroski, et al. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity. Sci Transl Med. 2023 Oct 25;15(719):eadh1892.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149665/BMS-684-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149665/BMS-684-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
313552-29-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1114396-01 0.02 mg (E-Coli)
Recombinant Lactobacillus reuteri Phosphoglucosamine mutase (glmM)
Ask
View Details MBS1114396-02 0.02 mg (Yeast)
Recombinant Lactobacillus reuteri Phosphoglucosamine mutase (glmM)
Ask
View Details 
MBS1114396-03 0.1 mg (E-Coli)
Recombinant Lactobacillus reuteri Phosphoglucosamine mutase (glmM)
Ask
View Details MBS1114396-04 0.1 mg (Yeast)
Recombinant Lactobacillus reuteri Phosphoglucosamine mutase (glmM)
Ask
View Details MBS1114396-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus reuteri Phosphoglucosamine mutase (glmM)
Ask
View Details